Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-17
2007-04-17
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S286000, C514S295000, C544S343000, C546S063000, C546S097000
Reexamination Certificate
active
10336508
ABSTRACT:
This invention is directed to compounds of the formula (I):and their pharmaceutically acceptable salts, wherein R1, R2, and R3are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
REFERENCES:
patent: 3471503 (1969-10-01), Carson
patent: 6410550 (2002-06-01), Coe et al.
patent: 6887884 (2005-05-01), Coe et al.
patent: 2005/0020616 (2005-01-01), Coe et al.
patent: EP 0955301 (1999-11-01), None
patent: WO 9955680 (1999-11-01), None
P. Mazzocchi et al., “Synthesis and Pharmacological Activity of 2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepines,”J. Med. Chem., 22(4), 455-457 (1979).
Brooks Paige Roanne Palmer
Coe Jotham Wadsworth
Coleman Brenda
Joran A. David
Pfizer Inc
Zelson Steve T.
LandOfFree
Aryl fused azapolycyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl fused azapolycyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl fused azapolycyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3797853